A study presented at #ESUR2026 compared 250 prostate MRI cases before and after implementation of Prostate Intelligence (Pi™). Clinically significant cancer detection increased from 28% to 40%, with no clear evidence of automation bias and fewer negative biopsies.

Attending #ESUR2026? Meet the Lucida Medical team at Booth 1 in Paris to explore Pi™, discuss AI in prostate cancer diagnosis, and connect with our team. Book a meeting: bookings.cloud.microsoft/boo…

Prostate Intelligence (Pi™) is now live across 4 NHS Trusts in Greater Manchester, funded by the NHS Cancer Programme & supported by SBRI Healthcare. Pi™ helps radiologists assess prostate MRI scans, supporting faster cancer diagnosis. Learn more: gmcancer.org.uk/ai-prostate-…

Antony Rix, founder and CEO of @LucidaMedical, joins the Healthcare Today Podcast this week to talk about the good and the bad of cancer screening... healthcaretoday.com/article/… #CancerScreening #HealthTech #ProstateCancer #EarlyDiagnosis #Podcast #PatientCare

Exciting news: Robin Barclay joins Lucida Medical as Chief Operating Officer! His expertise in scaling healthcare businesses will help us expand internationally and deliver impact for clinicians and patients. Read more: lucidamedical.com/chief-oper…

We’ve had a fantastic two days at #UKIO in Liverpool - catching up with familiar faces, meeting new ones, and joining the conversations happening across the conference. Always inspiring to be part of this community!

Heading to BAUS 2026! Find us at Booth 25 and learn more about our work on AI‑supported MRI pathways, including our contribution to the IP1‑PROSTAGRAM study (P17‑2, 17 June). Looking forward to connecting! #BAUS @BAUSurology

June is a busy month for us! Meet us in Leeds (2 June), Derby (4 June), Liverpool for #UKIO (8–10 June), London for #BAUS (15–17 June, Booth 25) and #RCR AI (29–30 June, Booth 4). Looking forward to seeing colleagues across the UK!

A great #BSUR2026 in Birmingham! Insightful discussions on AI in prostate cancer pathways following Dr Antony Rix’s session, and valuable conversations at the booth about Pi™ in everyday reporting. Thank you to the BSUR community for the warm engagement!

A look back at our Sips & Insights evening in Kraków! Dr Luca Russo (@lrusso_md) shared his experience with Prostate Intelligence (Pi™), sparking a great discussion among colleagues about AI in the prostate cancer pathway. Thank you to everyone who joined us 🙌

Lucida Medical is heading to BSUR in Birmingham! Join Dr Antony Rix on 21 May, 13:15–13:45 for insights on AI in prostate cancer pathways. Visit us at Booth 1 or book a meeting: outlook.office.com/book/BSUR…

We’re pleased to announce the nine high-potential innovators selected for the Grow #DigitalHealth Midlands 2026 cohort delivered in collaboration by @Healthinn_em & HIWM. Meet the innovators: healthinnovationwestmidlands… #HealthInnovation #NHS #MedTech #WestMidlands #EastMidlands

BSUR are super excited about the upcoming conference in Birmingham Thanks to all the great sponsors below who enable us to put on such a great event @LucidaMedical @CanonUKandIE @HLHImagingGroup @ArgonMedical @QuibimBiomarker @Bayer @SiemensHealth @QuibimBiomarker @DeepHealthEU

Following last week’s software release, we’re highlighting one of the updates designed to make clinicians’ work easier: segmentation editing. Pi™ lets clinicians adjust, remove or draw lesion segmentations before sending to PACS, giving more control and a faster workflow.

Lucida Medical is now a member of AXREM, the UK’s leading association for imaging, radiotherapy, healthcare IT and care equipment. We’re excited to collaborate with fellow members, advance patient outcomes, and contribute to the AXREM AI Special Focus Group!

Lucida Medical has secured £8.7m in funding led by IW Capital, with participation from XTX Ventures and Macmillan Cancer Support. This investment will advance our patented AI for prostate cancer diagnosis and support our international expansion. lucidamedical.com/lucida-med…